Epidural steroid injections safety recommendations by the multi-society pain workgroup (MPW): More regulations without evidence or clarification

Pain Physician

Volumn 17, Issue 5, 2014, Pages E575-E588

  Manchikanti, Laxmaiah ^a,b   Falco, Frank J E ^c,d   Benyamin, Ramsin M ^e,f   Gharibo, Christopher G ^g   Candido, Kenneth D ^h   Hirsch, Joshua A ⁱ  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c Mid Atlantic Spine and Pain Physicians   (United States)

^d TEMPLE UNIVERSITY HOSPITAL   (United States)

^e MILLENNIUM PAIN CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g NYU HOSPITAL FOR JOINT DISEASES   (United States)

^h UNIVERSITY OF ILLINOIS   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; STEROID;

ARTICLE; BRAIN INFARCTION; CERVICAL INTERLAMINAR EPIDURAL INJECTION; CERVICAL SPINAL CORD INFARCTION; CERVICAL TRANSFORAMINAL EPIDURAL INJECTION; DEATH; DRUG ADMINISTRATION ROUTE; DRUG LABELING; DRUG SAFETY; EPIDURAL SPACE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN; INFARCTION; LUMBAR INTERLAMINAR EPIDURAL INJECTION; LUMBAR TRANSFORAMINAL EPIDURAL INJECTION; MEDICATION ERROR; MULTI SOCIETY PAIN WORKGROUP; OFF LABEL DRUG USE; PHYSICIAN; RISK; SEIZURE; SPINAL CORD ISCHEMIA; ANALGESIA; EPIDURAL DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; LEGISLATION AND JURISPRUDENCE; MEDICAL SOCIETY; PRACTICE GUIDELINE; STANDARDS; UNITED STATES;

HUMANS; INJECTIONS, EPIDURAL; INJECTIONS, SPINAL; PAIN MANAGEMENT; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; STEROIDS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84907286324     PISSN: 15333159     EISSN: 21501149     Source Type: Journal    
DOI: None     Document Type: Article

References (122)

1. U.S. Food and Drug Administration. News Release. FDA approves extendedrelease, single-entity hydrocodone product. October 25, 2013. www.fda.gov/newsevents/newsroom/ pressannouncements/ucm372287.htm
2. Manchikanti L, Candido KD, Singh V, Gharibo CG, Boswell MV, Benyamin RM, Falco FJE, Grider JS, Diwan S, Staats PS, Hirsch JA. Epidural steroid warning controversy still dogging FDA. Pain Physician 2014; 17:E451-E474.
3. Manchikanti L, Atluri S, Candido KD, Boswell MV, Simopoulos TT, Grider JS, Falco FJE, Hirsch JA. Zohydro™ approval by Food and Drug Administration: Controversial or frightening? Pain Physician 2014; 17:E437-E450.
4. Candido KD, Knezevic N., Chien GC, Deer TR. The Food and Drug Administration’s recent action on April 23, 2014 failed to appropriately address safety concerns about epidural steroid use. Pain Physician 2014; 17:E509-E524.
5. Friedman M, Friedman R. Who protects the consumer? In: Free to Choose. Harvest House, Eugene, 1980, pp 203-210.
6. TAKE IT TO THE LIMITS: Milton Friedman on Libertarianism. Transcript from television show filmed February 10, 1999. The Hoover Institute. www.hoover. org/multimedia/uncommon knowledge/ 26936
7. DiMasi JA. The value of improving the productivity of the drug development process: Faster times and better decisions. Pharmacoeconomics 2002; 20:1-10.
8. Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA 2014; 311:368-377.
9. Epstein RA. The FDA’s misguided regulation of stem-cell procedures: How administrative overreach blocks medical innovation. Manhattan Institute for Policy Research; September 2013.
10. Carpenter DP. The political economy of FDA drug review: Processing, politics, and lessons for policy. Health Aff (Millwood) 2004; 23:52-63.
11. Henderson D. Panel: FDA needs more power, funds. Boston Globe, September 23, 2006.
12. Institute of Health of the National Academies, Committee on the Assessment of the US Drug Safety System. The Future of Drug Safety: Promoting and Protecting the Health of the Public. The National Academies Press, Washington, DC, 2006.
13. U.S. Food and Drug Administration. Drug Safety Communications. FDA Drug Safety Communication: FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain. April 23, 2014. www.fda.gov/downloads/ Drugs/Drug-Safety/UCM394286.pdf
14. Letter to Margaret Hamburg, MD, Commissioner, and Salma Lemtouni, MD, MPH, Office of the Center Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA), RE: FDA Safe Use Initiative of Epidural Steroids Evaluation with Assignment of Responsibility to Multisociety Pain Workgroup (MPW) from American Society of Interventional Pain Physicians (ASIPP) and 1,040 interventional pain physicians, June 26, 2014.
15. Work group passes epidural steroid injection consensus in response to FDA warning. Healio Spine Surgery, August 1, 2014. www.healio.com/spine-surgery/guidelines/ news/online/%7B3fb7ac39-daf3- 4305-9d37-6089d51a95d7%7D/workgroup- passes-epidural-steroid-injection- consensus-in-response-to-fdawarning
16. American Society of Anesthesiologists. FDA warns of neurological risks with epidural corticosteroid injections for pain; ASA collaborating with medical organizations to develop recommendations on safe use of epidural steroid injections, April 25, 2014. www.asahq.org/For-Members/Advocacy/ Washington-Alerts/FDA-Warns-of- Neurological-Risks-with-Epidural-Corticosteroid- Injections-for-Pain.aspx
17. American Society of Anesthesiologists. San Francisco chronicle anesthesiologists focus on patient safety, October 15, 2013. www.asahq.org/For-the-Public-and- Media/Press-Room/Anesthesia-Topicsin- the-News/San-Francisco-Chronicle- Oct-15-2013.aspx
18. American Society of Anesthesiologists. ASA Formally responding to FDA warning on injection of corticosteroids into epidural space, July 14, 2014. www.asahq.org/For-Members/Advocacy/ Washington-Alerts/ASA-Formally- Responding-to-FDA-Warning-on-Injection- of-Corticosteroids-into-Epidural- Space.aspx
19. International Spinal Intervention Society. Update on ISIS Response to FDA Statement on ESIs. www.spinalinjection.org/?page=FDAESI
20. Epidural Steroid Injections safety recommendations passed by the Multi--Society Pain Workgroup (MPW). A manuscript is currently being developed for publication. http://1515docs.org/pdfs/ESIs_Final_ Recommendations.pdf
21. Salma Lemtouni, MD, MPH, Safe Use Initiative, Office of the Center Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration RE: Invitation to participate in guidelines for epidural steroid injections, August 23, 2012.
22. Letter to Louis Jacques, MD, Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services, from American Society of Interventional Pain Physicians RE: Response to the Published Potential NCD Topics on 11/27/2012: Epidural and transforaminal injections., December 17, 2012.
23. Letter to Louis Jacques, MD, Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services from American Society of Interventional Pain Physicians RE: LCD for most commonly performed interventional techniques – epidurals, facet joint interventions, and sacroiliac joint injections, for national adoption, April 26, 2013.
24. Letter to Louis Jacques, MD, Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services, from American Society of Interventional Pain Physicians RE: Multi-Specialty Pain Workgroup, July 30, 2013.
25. Comment letter to Palmetto on LCD Policies of Epidural Steroid Injections, Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy, November 18, 2013.
26. Comment letter to CGS Administrators, LLC, on LCD Policies of Epidural Steroid Injections, Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy, October 21, 2013.
27. Comment letter to Cahaba Government Benefit Administrators, LLC, on LCD Policy of Epidural Steroid Injections, November 19, 2013.
28. Noridian Healthcare Solutions, LLC. Local Coverage Determination (LCD). Lumbar Epidural Injections (L33836). Effective Date: 2/26/2014.
29. Noridian Healthcare Solutions, LLC. Local Coverage Determination (LCD). Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy (L33842). Effective Date: 3/5/2014.
30. CGS Administrators, LLC. Local Coverage Determination (LCD). Lumbar Epidural Steroid Injections (L34404). Effective Date: 1/25/2014.
31. CGS Administrators, LLC. Local Coverage Determination (LCD). Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy (L34409). Effective Date: 1/25/2014.
32. Palmetto GBA. Local Coverage Determination (LCD). Lumbar Epidural Steroid Injections (DL34336). Effective Date 5/20/2014.
33. Palmetto GBA. Local Coverage Determination (LCD). Paravertebral Facet Joint Block (L33439). Effective Date 10/1/2014.
34. Cahaba Government Benefit Administrators, LLC. Local Coverage Determination (LCD). Surgery: Lumbar Facet Blockade (L32116). Effective Date 1/1/2012.
35. National Government Services, Inc. Draft Local Coverage Determination (LCD). Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy (DL35336). Comment Period Start Date: 6/5/2014.
36. National Government Services, Inc. Draft Local Coverage Determination (LCD). Lumbar Epidural Injections (DL35338). Comment Period Start Date: 6/5/2014.
37. Letter to Division of Dockets Management, Food and Drug Administration, Department of Health and Human Services, from American Society of Interventional Pain Physicians RE FDA Citizens Petition, September 3, 2014.
38. Scanlon GC, Moeller-Bertram T, Romanowsky SM, Wallace MS. Cervical transforaminal epidural steroid injections: More dangerous than we think? Spine (Phila Pa 1976) 2007; 32:1249-1256.
39. Engel A, King W, MacVicar J; Standards Division of the International Spine Intervention Society. The effectiveness and risks of fluoroscopically guided cervical transforaminal injections of steroids: A systematic review with comprehensive analysis of the published data. Pain Med 2014; 15:386-402.
40. Windsor RE, Storm S, Sugar R, Nagula D. Cervical transforaminal injection: Review of the literature, complications, and a suggested technique. Pain Physician 2003; 6:457-465.
41. Wallace MA, Fukui MB, Williams RL, Ku A, Baghai P. Complications of cervical selective nerve root blocks performed with fluoroscopic guidance. AJR Am J Roentgenol 2007; 188:1218-1221.
42. Lee JH, Lee JK, Seo BR, Moon SJ, Kim JH, Kim SH. Spinal cord injury produced by direct damage during cervical transforaminal epidural injection. Reg Anesth Pain Med 2008; 33:377-379.
43. Beckman WA, Mendez RJ, Paine GF, Mazzilli MA. Cerebellar herniation after cervical transforaminal epidural injection. Reg Anesth Pain Med 2006; 31:282-285.
44. Ludwig MA, Burns SP. Spinal cord infarction following cervical transforaminal epidural injection: A case report. Spine (Phila Pa 1976) 2005; 30:E266-E268.
45. Tiso RL, Cutler T, Catania JA, Whalen K. Adverse central nervous system sequelae after selective transforaminal block: The role of corticosteroids. Spine J 2004; 4:468-474.
46. Suresh S, Berman J, Connell DA. Cerebellar and brainstem infarction as a complication of CT-guided transforaminal cervical nerve root block. Skeletal Radiol 2007; 36:449-452.
47. Popescu A, Gardner K. An usual mechanisms for spinal cord infarction – case report. Ann Neurol 2007; 62:32.
48. Rathmell JP. Toward improving the safety of transforaminal injection. Anesth Analg 2009; 109:8-10.
49. Kim do W, Han KR, Kim C, Chae YJ. Intravascular flow patterns in transforaminal epidural injections: A comparative study of the cervical and lumbar vertebral segments. Anesth Analg 2009; 109:233-239.
50. El Abd OH, Amadera JE, Pimentel DC, Pimentel TS. Intravascular flow detection during transforaminal epidural injections: A prospective assessment. Pain Physician 2014; 17:21-27.
51. Smuck M, Tang CT, Fuller BJ. Incidence of simultaneous epidural and vascular injection during cervical transforaminal epidural injections. Spine (Phila Pa 1976) 2009; 34:E751-E755.
52. Furman MB, Giovanniello MT, O’Brien EM. Incidence of intravascular penetration in transforaminal cervical epidural steroid injections. Spine (Phila Pa 1976) 2003; 28:21-25.
53. Lee MH, Yang KS, Kim YH, Jung HD, Lim SJ, Moon DE. Accuracy of live fluoroscopy to detect intravascular injection during lumbar transforaminal epidural injections. Korean J Pain 2010; 23:18-23.
54. Huntoon MA. Anatomy of the cervical intervertebral foramina: Vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain 2005; 117:104-111.
55. Beckworth WJ, Sood R, Katzer AF, Wu B. Anomalous location of the vertebral artery in relation to the neural foramen. Implications for cervical transforaminal epidural steroid injections. Pain Med 2013; 14:1119-1125.
56. Hoeft MA, Rathmell JP, Monsey RD, Fonda BJ. Cervical transforaminal injection and the radicular artery: Variation in anatomical location within the cervical intervertebral foramina. Reg Anesth Pain Med 2006; 31:270-274.
57. Popescu A, Lai D, Lu A, Gardner K. Stroke following epidural injections- -case report and review of literature. J Neuroimaging 2013; 23:118-121.
58. Karasek M, Bogduk N. Temporary neurologic deficit after cervical transforaminal injection of local anesthetic. Pain Med 2004; 5:202-205.
59. Atluri S, Glaser SE, Shah RV, Sudarshan G. Needle position analysis in cases of paralysis from transforaminal epidurals: Consider alternative approaches to traditional techniques. Pain Physician 2013; 16:321-334.
60. Glaser SE, Falco FJE. Paraplegia following a thoracolumbar transforaminal epidural steroid injection. Pain Physician 2005; 8:309-314.
61. Rathmell JP, Aprill C, Bogduk N. Cervical transforaminal injection of steroids. Anesthesiology 2004; 100:1595-1600.
62. Murthy NS, Maus TP, Behrns CL. Intraforaminal location of the great anterior radiculomedullary artery (artery of Adamkiewicz): A retrospective review. Pain Med 2010; 11:1756-1764.
63. Alleyne CH Jr, Cawley CM, Shengelaia GG, Barrow DL. Microsurgical anatomy of the artery of Adamkiewicz and its segmental artery. J Neurosurg 1998; 89:791-795.
64. Kroszczynski AC, Kohan K, Kurowski M, Olson TR, Downie SA. Intraforaminal location of thoracolumbar anterior medullary arteries. Pain Med 2013; 14:808-812.
65. Rauschning W. Normal and pathological anatomy of the nerve root canals. Spine (Phila Pa 1976) 1987; 2:1008-1019.
66. Takase K, Sawamura Y, Igarashi K, Chiba Y, Haga K, Saito H, Takahashi S. Demonstration of the artery of Adamkiewicz at multi–detector row helical CT. Radiology 2002; 223:39-45.
67. Gao L, Wang L, Su B, Wang P, Ye J, Shen H. The vascular supply to the spinal cord and its relationship to anterior spine surgical approaches. Spine J 2013; 13:966-973.
68. Glaser SE, Shah RV. Root cause analysis of paraplegia following transforaminal epidural steroid injections: The ‘unsafe’ triangle. Pain Physician 2010; 13:237-244.
69. Shah RV. Paraplegia following thoracic and lumbar transforaminal epidural steroid injections: How relevant is physician negligence? J Neurointerv Surg 2014; 6:166-168.
70. Shah RV. Paraplegia following thoracic and lumbar transforaminal epidural steroid injections: How relevant are particulate steroids? Pain Pract 2014; 14:297-300.
71. Kennedy DJ, Dreyfuss P, Aprill CN, Bogduk N. Paraplegia following imageguided transforaminal lumbar spine epidural steroid injection: Two case reports. Pain Med 2009; 10:1389-1394.
72. Cho CH. Cervical nerve injection: Computed tomography guidance with intravenous contrast and extraforaminal needle placement. Series of seven consecutive case reports. Spine J 2010; 10:E1-E6.
73. Ma D., Gilula LA, Riew KD. Complications of fluoroscopically guided extraforaminal cervical nerve blocks. Ananalysis of 1036 injections. J Bone Joint Surg Am 2005, 87:1025-1030.
74. Gilula LA, Ma D. A cervical nerve block approach to improve safety. AJR Am J Roentgenol 2007, 189:563-565.
75. Wolter T, Mohadjer M, Berlis A, Knoeller S. Cervical CT-guided, selective nerve root blocks: Improved safety by dorsal approach. Am J Neuroradiol 2009; 30:336-337.
76. Wald JT, Maus TP, Geske JR, Carter RE, Diehn FE, Kaufmann TJ, Morris JM, Murthy NS, Thielen KR. Safety and efficacy of CT-guided transforaminal cervical epidural steroid injections using a posterior approach. Am J Neuroradiol 2012; 33:415-419.
77. Cyteval C, Thomas E, Decoux E, Sarrabere MP, Cottin A, Blotman F, Taourel P. Cervical radiculopathy: Open study on percutaneous periradicular foraminal steroid infiltration performed under CT control in 30 patients. Am J Neuroradiol 2004; 25:441-445.
78. Wagner AL. CT fluoroscopic-guided cervical nerve root blocks. Am J Neuroradiol 2005; 26:43-44.
79. Schultz DM, Manchikanti L, Racz GB. Cervical transforaminal epidural injections. In: Manchikanti L, Singh V (eds.). Interventional Techniques in Chronic Spinal Pain. ASIPP Publishing, Paducah, KY, 2007, pp 455-478.
80. Morvan G, Mompoint D, Bard M, Levi- Valensin G: Direct intra-foraminal injection of corticosteroids in the treatment of cervico-brachial pain. In: Bard M, Laredo J (eds). Interventional Radiology in Bone and Joint.: Springer-Verlag, New York, 1988. pp 253-257.
81. Vallee JN, Feydy A, Carlier RY, Mutschler C, Mompoint D, Vallee CA: Chronic cervical radiculopathy: Lateral approach periradicular corticosteroid injection. Radiology 2001; 218:886-892.
82. Kloth DS, Calodney AK, Derby R, Lagattuta FP, O’Neill C, Yurth E, Miller LE, Block JE. Improving the safety of transforaminal epidural steroid injections in the treatment of cervical radiculopathy. Pain Physician 2011; 14:285-293.
83. Manchikanti L, Falco FJ, Diwan S, Hirsch JA, Smith HS. Cervical radicular pain: The role of interlaminar and transforaminal epidural injections. Curr Pain Headache Rep 2014; 18:389.
84. Sundara Rajan R, Bhatia A. Particulate and non-particulate steroids in lumbar transforaminal epidural injections. Pain Med 2014; 15:877-878.
85. Shin J, Kim YC, Lee SC, Kim JH. A comparison of Quincke and Whitacre needles with respect to risk of intravascular uptake in S1 transforaminal epidural steroid injections: A randomized trial of 1376 cases. Anesth Analg 2013; 117:1241-1247.
86. Manchikanti L, Cash KA, Pampati V, Falco FJE. Transforaminal epidural injections in chronic lumbar disc herniation: A randomized, double-blind, active- control trial. Pain Physician 2014; 17:E489-E501.
87. Manchikanti L, Cash KA, McManus CD, Pampati V. Fluoroscopic caudal epidural injections in managing chronic axial low back pain without disc herniation, radiculitis or facet joint pain. J Pain Res 2012; 5:381-390.
88. Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Effect of fluoroscopically guided caudal epidural steroid or local anesthetic injections in the treatment of lumbar disc herniation and radiculitis: A randomized, controlled, double blind trial with a two-year follow-up. Pain Physician 2012; 15:273-286.
89. Ilkhchoui Y, Koshkin E. A blunt needle (Epimed(®)) does not eliminate the risk of vascular penetration during transforaminal epidural injection. Surg Neurol Int 2013; 4:S404-S406.
90. Chang-Chien GC, Candido KD, Knezevic NN. Digital subtraction angiography does not reliably prevent paraplegia associated with lumbar transforaminal epidural steroid injection. Pain Physician 2012; 15:515-523.
91. Heavner JE, Racz GB. Using procedurespecific needles: What is blunt? South Med J 2010; 103:604.
92. Heavner JE, Racz GB, Jenigiri B, Lehman T, Day MR. Sharp versus blunt needle: A comparative study of penetration of internal structures and bleeding in dogs. Pain Pract 2003; 3:226-231.
93. Smuck M, Yu AJ, Tang CT, Zemper E. Influence of needle type on the incidence of intravascular injection during transforaminal epidural injections: A comparison of short-bevel and long-bevel needles. Spine J 2010; 10:367-371.
94. El-Yahchouchi C, Geske JR, Carter RE, Diehn FE, Wald JT, Murthy NS, Kaufmann TJ, Thielen KR, Morris JM, Amrami KK, Maus TP. The noninferiority of the nonparticulate steroid dexamethasone vs the particulate steroids betamethasone and triamcinolone in lumbar transforaminal epidural steroid injections. Pain Med 2013; 14:1650-1657.
95. Schultz DM. Fluoroscopy in the interventional pain unit: A physician perspective. In: Manchikanti L, Singh V (eds). Interventional Techniques in Chronic Spinal Pain, ASIPP Publishing, Paducah, KY, 2007, pp 125-142.
96. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and The Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings www.cdc.gov/ncidod/dhqp/pdf/isolation2007. pdf
97. Bose B. Quadriparesis following cervical epidural steroid injections: Case report and review of the literature. Spine J 2005; 5:558-563.
98. Ziai WC, Ardelt AA, Llinas RH. Brainstem stroke following uncomplicated cervical epidural steroid injection. Arch Neurol 2006; 63:1643-1646.
99. Singh R, Panagos A. Quadriparesis following cervical epidural steroid injections. Spine J 2006; 6:349.
100. Lirk P, Colvin J, Steger B, Colvin HP, Keller C, Rieder J, Kolbitsch C, Moriggl B. Incidence of lower thoracic ligamentum flavum midline gaps. Br J Anaesth 2005; 94:852-855.
101. Lirk P, Moriggl B, Colvin J, Keller C, Kirchmair L, Rieder J, Kolbitsch C. The incidence of lumbar ligamentum flavum midline gaps. Anesth Analg 2004; 98:1178-1180.
102. Botwin KP, Castellanos R, Rao S, Hanna AF, Torres-Ramos FM, Gruber RD, Bouchlas CG, Fuoco GS. Complications of fluoroscopically guided interlaminar cervical epidural injections. Arch Phys Med Rehabil 2003; 84:627-633.
103. Manchikanti L, Cash KA, Pampati V, Malla Y. Two-year follow-up results of fluoroscopic cervical epidural injections in chronic axial or discogenic neck pain: A randomized, double-blind, controlled trial. Int J Med Sci 2014; 11:309-320.
104. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. A randomized, double- blind, active control trial of fluoroscopic cervical interlaminar epidural injections in chronic pain of cervical disc herniation: Results of a 2-year follow-up. Pain Physician 2013; 16:465-478.
105. Manchikanti L, Malla Y, Cash KA, McManus CD, Pampati V. Fluoroscopic epidural injections in cervical spinal stenosis: Preliminary results of a randomized, double-blind, active control trial. Pain Physician 2012; 15:E59-E70.
106. Manchikanti L, Malla Y, Cash KA, McManus CD, Pampati V. Fluoroscopic cervical interlaminar epidural injections in managing chronic pain of cervical postsurgery syndrome: Preliminary results of a randomized, double-blind active control trial. Pain Physician 2012; 15:13-26.
107. Diwan SA, Manchikanti L, Benyamin RM, Bryce DA, Geffert S, Hameed H, Sharma ML, Abdi S, Falco FJE. Effectiveness of cervical epidural injections in the management of chronic neck and upper extremity pain. Pain Physician 2012; 15:E405-E434.
108. Candido KD, Knezevic N. Cervical epidural steroid injections for the treatment of cervical spinal (neck) pain. Curr Pain Headache Rep 2013; 17:314.
109. Ghahreman A, Ferch R, Bogduk N. The efficacy of transforaminal injection of steroids for the treatment of lumbar radicular pain. Pain Med 2010; 11:1149-1168.
110. Macvicar J, King W, Landers MH, Bogduk N. The effectiveness of lumbar transforaminal injection of steroids: A comprehensive review with systematic analysis of the published data. Pain Med 2013; 14:14-28.
111. Manchikanti L, Buenaventura RM, Manchikanti KN, Ruan X, Gupta S, Smith HS, Christo PJ, Ward SP. Effectiveness of therapeutic lumbar transforaminal epidural steroid injections in managing lumbar spinal pain. Pain Physician 2012; 15:E199-E245.
112. Manchikanti L, Benyamin RM, Falco FJ, Kaye AD, Hirsch JA. Do epidural injections provide short- and long-term relief for lumbar disc herniation? A systematic review. Clin Orthop Relat Res 2014 Feb 11. [Epub ahead of print].
113. Manchikanti L, Pampati V, Falco FJE, Hirsch JA. Assessment of the growth of epidural injections in the Medicare population from 2000 to 2011. Pain Physician 2013; 16:E349-E364.
114. Cook TM, Counsell D, Wildsmith JA; Royal College of Anaesthetists Third National Audit Project. Major complications of central neuraxial block: Report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 2009; 102:179-190.
115. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E (eds); Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Institute of Medicine. Clinical Practice Guidelines We Can Trust. The National Academies Press, Washington, DC, 2011.
116. Manchikanti L, Falco FJE, Singh V, Benyamin RM, Racz GB, Helm II S, Caraway DL, Calodney AK, Snook LT, Smith HS, Gupta S, Ward SP, Grider JS, Hirsch JA. An update of comprehensive evidence- based guidelines for interventional techniques of chronic spinal pain. Part I: Introduction and general considerations. Pain Physician 2013; 16:S1-S48.
117. National Comprehensive Cancer Network. NCCN Guidelines® and Derivative Information Products: User Guide. Transparency of the NCCN Guidelines, the NCCN Compendium, and the NCCN Templates Development. http:// www.nccn.org/professionals/transparency. asp
118. Talwalkar JA. Improving the transparency and trustworthiness of subspecialtybased clinical practice guidelines. Mayo Clin Proc 2014; 89:5-7.
119. Smith Begolka W, Elston DM, Beutner KR. challenges and establishing transparency. J Am Acad Dermatol 2011; 64:e105-e112.
120. The Cochrane Collaboration. Cochrane Reviews. www.cochrane.org/cochranereviews
121. Chou R, Atlas SJ, Loeser JD, Rosenquist RW, Stanos SP. Guideline warfare over interventional therapies for low back pain: Can we raise the level of discourse? J Pain 2011; 12:833-839.
122. Manchikanti L, Benyamin RM, Falco FJE, Caraway DL, Datta S, Hirsch JA. Guidelines warfare over interventional techniques: Is there a lack of discourse or straw man? Pain Physician 2012; 15:E1-E26.